Related Experiment Video

Updated: Aug 25, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

[Therapeutic trials for the patients with muscle glycogen storage diseases]

Hideo Sugie1

  • 1Department of Pediatrics (Pediatric Neurology), Hamamatsu City Medical Center for Developmental Medicine, Hamakita, Shizuoka. h-sugie@umin.ac.jp

No to Hattatsu = Brain and Development
|March 23, 2004
PubMed

Insights

Muscle glycogen storage diseases (GSDs) are metabolic disorders. Current and emerging therapies include gene therapy, substrate supplementation, and enzyme replacement, with trials for GSD types V, II, and IX.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Context:

  • Muscle glycogen storage diseases (GSDs) represent a group of inherited metabolic disorders.
  • These conditions arise from genetic defects affecting glycogen metabolism in muscle tissue.

Purpose:

  • To explore current and potential therapeutic strategies for GSDs.
  • To highlight the importance of various treatment modalities beyond gene therapy.

Summary:

  • Gene therapy offers a potential cure by restoring deficient enzymes in GSDs.
  • Alternative treatments like substrate supplementation, residual enzyme activation, and enzyme replacement are crucial.
  • Ongoing trials investigate vitamin B6 and cornstarch for GSD V, enzyme replacement for GSD II, and ketogenic diets for GSD IX.

Impact:

  • Advances in GSD treatment offer hope for improved patient outcomes.
  • Understanding diverse therapeutic approaches can guide clinical management and research.
  • This research underscores the multifaceted nature of treating rare metabolic diseases.

More Related Videos

Radiochemical Assessment of Glycogen Synthase Enzyme Activity in Animal Tissue02:30

Radiochemical Assessment of Glycogen Synthase Enzyme Activity in Animal Tissue

Published on: October 24, 2025

Quantification of Subcellular Glycogen Distribution in Skeletal Muscle Fibers using Transmission Electron Microscopy08:32

Quantification of Subcellular Glycogen Distribution in Skeletal Muscle Fibers using Transmission Electron Microscopy

Published on: February 7, 2022

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...